CClinicalTrials.gg
CompletedNCT07483619VR-CAPAUpdated Mar 19, 2026

Virtual Reality During Coronary Angiography: Effects on Pain and Anxiety

An interventional study of Virtual Reality Headset in Coronary Angiography (CAG), Anxiety and Pain, sponsored by Koç University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-03-19.

Sponsored by Koç University · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 4 years 2 months after the study started (first participant enrolled Jan 2022, registered Mar 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study investigated whether virtual reality (VR) can reduce pain and anxiety in patients undergoing coronary angiography. Coronary angiography is a common cardiac procedure performed under local anesthesia while patients remain awake, which can cause significant pain and anxiety.

Adult patients scheduled for elective coronary angiography were randomly assigned to two groups: one group watched a nature-themed VR video during the procedure, while the control group received standard care. Pain and anxiety levels were measured before and after the procedure using validated scales.

The findings of this study may help healthcare providers offer a simple, non-pharmacological method to improve patient comfort during coronary angiography.

Read the detailed description

Coronary angiography is one of the most frequently performed invasive cardiac diagnostic procedures. Although the procedure is performed under local anesthesia, patients remain conscious throughout, and procedural pain and anxiety are commonly reported. Non-pharmacological interventions to manage these symptoms are increasingly being explored as adjuncts to standard care.

Virtual reality (VR) is an immersive technology that engages the user's visual and auditory senses, potentially distracting patients from procedural discomfort. This randomized controlled trial examined the effect of VR on pain and anxiety in patients undergoing elective coronary angiography.

Patients were randomized into two groups using a sealed envelope method. The VR group watched a pre-selected nature-themed video through a VR headset throughout the procedure. The control group received standard care without any additional intervention. Pain was assessed using the Visual Analog Scale (VAS) and anxiety was measured using the State-Trait Anxiety Inventory (STAI) before and after the procedure.

The study was conducted at a cardiology unit in Istanbul, Turkey, and was approved by the institutional ethics committee (Approval No: 2019-84). Written informed consent was obtained from all participants prior to enrollment.

02

Conditions studied

  • Coronary Angiography (CAG)
  • Anxiety
  • Pain
  • Virtual Reality

Keywords

  • Virtual reality
  • Coronary Angiography
  • Pain Management
  • Anxiety
  • Non-pharmacological Intervention
  • Randomized Controlled Trial
03

In context

Anxiety Disorders

4,868 studies on the registry are indexed under Anxiety Disorders; 1,390 are open to participants now.

This study's enrollment of 90 is above the median of 80 across 4,174 interventional studies indexed under Anxiety Disorders.

Browse Anxiety Disorders studies →

Lead sponsor

Koç University is the lead sponsor of 106 studies on the registry; 36 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Aged 18 years or older
  • Scheduled for elective coronary angiography
  • Conscious and oriented
  • Able to communicate verbally
  • No prior coronary angiography experience
  • Willing to participate and provided written informed consent

Exclusion criteria

Exclusion Criteria:

  • History of psychiatric disorder or use of psychiatric medication
  • Visual or hearing impairment that would prevent VR use
  • Hemodynamic instability
  • Emergency coronary angiography
  • Inability to complete the questionnaires
  • Prior experience with virtual reality
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
90 participants (actual)

Study arms

  • Experimental
    Virtual Reality Group

    Participants watched a nature-themed virtual reality video through a VR headset throughout the coronary angiography procedure in addition to standard care.

    Device: Virtual Reality Headset

  • No intervention
    Control Group

    Participants received standard care without any additional intervention during coronary angiography.

Interventions

  • DeviceVirtual Reality Headset

    Participants in the VR group wore a virtual reality headset and watched a pre-selected nature-themed video throughout the coronary angiography procedure. The VR intervention was applied in addition to standard care and was maintained for the entire duration of the procedure.

06

What researchers measure

Primary outcomes

  1. Pain Intensity Measured by Visual Analog Scale (VAS)

    Pain was assessed using the Visual Analog Scale (VAS), a 10-cm horizontal scale where 0 indicates no pain and 10 indicates the worst imaginable pain.

    Time frame: Measured before and immediately after the coronary angiography procedure

Secondary outcomes

  1. State-Trait Anxiety Level Measured by State-Trait Anxiety Inventory (STAI-S)

    Anxiety was assessed using the State-Trait Anxiety Inventory (STAI), which measures state anxiety (STAI-S) and trait anxiety (STAI-T). State anxiety reflects current anxiety levels, while trait anxiety reflects general anxiety disposition. Higher scores indicate greater anxiety.

    Time frame: Measured before and immediately after the coronary angiography procedure

07

Study locations

1 site
  • Koç University
    Istanbul, Turkey (Türkiye)
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 19, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07483619
Lead sponsor
Koç University
Responsible party
Meryem Ayvaz (Assistant Professor, Koç University) — Principal investigator
First posted
Mar 19, 2026
Start date
Jan 1, 2022
Primary completion
Feb 1, 2023
Completion
Feb 1, 2023
Last update
Mar 19, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion